Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sober

Showing results (441-450 of 516) with videos related to

Pageof 52
Sort By:
Journal of the American Academy of Dermatology|February 14, 2014
Relationships among primary tumor size, number of involved nodes, and survival for 8044 cases of Merkel cell carcinomaJayasri G Iyer, Barry E Storer, Kelly G Paulson, et al.
Journal of the American Academy of Dermatology|August 27, 2011
Guidelines of care for the management of primary cutaneous melanoma. American Academy of DermatologyChristopher K Bichakjian, Allan C Halpern, Timothy M Johnson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 10, 2005
Immunization using autologous dendritic cells pulsed with the melanoma-associated antigen gp100-derived G280-9V peptide elicits CD8+ immunityGerald P Linette, Dongsheng Zhang, F Stephen Hodi, et al.
Journal of the American Academy of Dermatology|November 6, 2018
Guidelines of care for the management of primary cutaneous melanomaSusan M Swetter, Hensin Tsao, Christopher K Bichakjian, et al.
Cancer|March 1, 1981
Malignant melanoma patients with positive nodes and relatively good prognoses: microstaging retains prognostic significance in clinical stage I melanoma patients with metastases to regional nodesC L Day, A J Sober, R A Lew, et al.
Human Gene Therapy|January 1, 1997
A phase I study of vaccination with autologous, irradiated melanoma cells engineered to secrete human granulocyte-macrophage colony stimulating factorG Dranoff, R Soiffer, T Lynch, et al.
Surgery|May 1, 1981
A prognostic model for clinical stage I melanoma of the lower extremity. Location on foot as independent risk factor for recurrent diseaseC L Day, A J Sober, A W Kopf, et al.
American Journal of Surgery|August 1, 1981
A prognostic model for clinical stage I melanoma of the trunk. Location near the midline is not an independent risk factor for recurrent diseaseC L Day, A J Sober, A W Kopf, et al.
Cancer Journal (Sudbury, Mass.)|July 6, 2000
Adjuvant high-dose interferon alfa-2b in patients with high-risk melanomaE Jonasch, U N Kumar, G P Linette, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 16, 2001
Final version of the American Joint Committee on Cancer staging system for cutaneous melanomaC M Balch, A C Buzaid, S J Soong, et al.
Pageof 52

Showing results (441-450 of 516) with videos related to

Sort By:
Pageof 52
Journal of the American Academy of Dermatology|February 14, 2014
Relationships among primary tumor size, number of involved nodes, and survival for 8044 cases of Merkel cell carcinomaJayasri G Iyer, Barry E Storer, Kelly G Paulson, et al.
Journal of the American Academy of Dermatology|August 27, 2011
Guidelines of care for the management of primary cutaneous melanoma. American Academy of DermatologyChristopher K Bichakjian, Allan C Halpern, Timothy M Johnson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 10, 2005
Immunization using autologous dendritic cells pulsed with the melanoma-associated antigen gp100-derived G280-9V peptide elicits CD8+ immunityGerald P Linette, Dongsheng Zhang, F Stephen Hodi, et al.
Journal of the American Academy of Dermatology|November 6, 2018
Guidelines of care for the management of primary cutaneous melanomaSusan M Swetter, Hensin Tsao, Christopher K Bichakjian, et al.
Cancer|March 1, 1981
Malignant melanoma patients with positive nodes and relatively good prognoses: microstaging retains prognostic significance in clinical stage I melanoma patients with metastases to regional nodesC L Day, A J Sober, R A Lew, et al.
Human Gene Therapy|January 1, 1997
A phase I study of vaccination with autologous, irradiated melanoma cells engineered to secrete human granulocyte-macrophage colony stimulating factorG Dranoff, R Soiffer, T Lynch, et al.
Surgery|May 1, 1981
A prognostic model for clinical stage I melanoma of the lower extremity. Location on foot as independent risk factor for recurrent diseaseC L Day, A J Sober, A W Kopf, et al.
American Journal of Surgery|August 1, 1981
A prognostic model for clinical stage I melanoma of the trunk. Location near the midline is not an independent risk factor for recurrent diseaseC L Day, A J Sober, A W Kopf, et al.
Cancer Journal (Sudbury, Mass.)|July 6, 2000
Adjuvant high-dose interferon alfa-2b in patients with high-risk melanomaE Jonasch, U N Kumar, G P Linette, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 16, 2001
Final version of the American Joint Committee on Cancer staging system for cutaneous melanomaC M Balch, A C Buzaid, S J Soong, et al.
Pageof 52